NeuroFlow is a HIPAA-compliant cloud-based platform that empowers health care providers to objectively track, assess, and engage patients using evidence-based practices to support their mental health.

NeuroFlow is the platform for getting patients with behavioral health issues better by supporting clinical teams with collaborative and measurement-based tools in all care settings.

NeuroFlow was founded in 2017 Christopher Molaro and Adam Pardes. The company is headquartered in Philadelphia, Pennsylvania.

NeuroFlow is committed to promoting behavioral health access across the care continuum.

NeuroFlow’s suite of HIPAA-compliant, cloud-based tools simplify remote patient monitoring and behavioral health integration across the continuum of care, including psychology, primary care, and pain management settings.


NeuroFlow combines workflow automation, an engagement platform, and applied AI to simplify remote patient monitoring, deliver risk stratification, and facilitate collaborative care. Hundreds of health systems, clinicians, and care teams are using NeuroFlow to bridge the gap between mental and physical health in order to improve patient outcomes and reduce the cost of care.


NeuroFlow is backed by Builders VC, Dreamit Ventures, Spring Point Partners, Red & Blue Ventures and others. The company raised $7.5M in a Series A financing on Dec 16, 2019. This new round brings NeuroFlow's total funding to $11M to date.



  • Year founded: 2017
  • Funding Info: $11M over 3 Rounds (Latest Funding Type: Series A)
  • Yearly Revenue: NA
  • Employee Size: 11-50
  • Business Valuation: NA
  • City/Town: Philadelphia
  • State: Pennsylvania
  • Country: United States
Related businesses